0001213900-21-036353.txt : 20210709 0001213900-21-036353.hdr.sgml : 20210709 20210709160633 ACCESSION NUMBER: 0001213900-21-036353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210707 FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moss David J CENTRAL INDEX KEY: 0001421930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 211082908 MAIL ADDRESS: STREET 1: C/O PEGASI ENERGY RESOURCES CORPORATION STREET 2: 218 N. BROADWAY, SUITE 204 CITY: TYLER STATE: TX ZIP: 75702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-07-07 0 0001711754 Inmune Bio, Inc. INMB 0001421930 Moss David J C/O INMUNE BIO INC. 980 NORTH FEDERAL HIGHWAY, SUITE 110 BOCA RATON, FL 33432 0 1 0 0 CFO, Treasurer & Secretary Common Stock 2021-07-07 2021-07-07 4 S 0 8698 20.0081 D 1214719 D Common Stock 2021-07-08 2021-07-08 4 S 0 16302 20.0891 D 1198417 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.03, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.14, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. /s/ David Moss 2021-07-09